Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Of The Tolerability, Safety, And Efficacy Of DMT310 For The Treatment Of Acne Rosacea

NCT05108025 is registered in ClinicalTrials.gov with Dermata Therapeutics as lead sponsor.

NCT NCT05108025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05108025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Of The Tolerability, Safety, And Efficacy Of DMT310 For The Treatment Of Acne Rosacea
Lead sponsor
Dermata Therapeutics
Phase
Phase 2
Overall status
Unknown status
Start date
November 15, 2021
Completion date
December 31, 2022
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne rosacea